Production (Stage)
biote Corp.
BTMD
$3.53
-$0.55-13.48%
NASDAQ
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -1.69% | -3.02% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -1.69% | -3.02% | |||
| Cost of Revenue | -11.84% | -5.72% | |||
| Gross Profit | 2.40% | -1.88% | |||
| SG&A Expenses | -11.90% | 30.87% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -11.88% | 16.38% | |||
| Operating Income | 85.14% | -59.93% | |||
| Income Before Tax | 1,530.74% | -107.69% | |||
| Income Tax Expenses | 134.36% | -247.06% | |||
| Earnings from Continuing Operations | 354.75% | -72.48% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -1,064.09% | 111.25% | |||
| Net Income | 270.46% | -65.40% | |||
| EBIT | 85.14% | -59.93% | |||
| EBITDA | 80.66% | -57.38% | |||
| EPS Basic | 267.99% | -65.65% | |||
| Normalized Basic EPS | -23.51% | -33.57% | |||
| EPS Diluted | 268.16% | -69.55% | |||
| Normalized Diluted EPS | -22.32% | -42.08% | |||
| Average Basic Shares Outstanding | 0.65% | 0.76% | |||
| Average Diluted Shares Outstanding | -0.90% | 15.59% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||